Highlights AstraZeneca PLC Xetra

Equities

Market Closed - Xetra Other stock markets 11:35:44 2024-05-31 EDT			5-day change	1st Jan Change
143.4 ^EUR	+1.31%		-0.80%	+17.40%

05-31	Health Care Stocks Climb On Drug News -- Health Care Roundup	DJ
05-31	Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	MT

Health Care Stocks Climb On Drug News -- Health Care Roundup	05-31	DJ
Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	05-31	MT
News Highlights: Top Company News of the Day - Friday at 1 PM ET	05-31	DJ
News Highlights : Top Company News of the Day - Friday at 11 AM ET	05-31	DJ
Battles over CEO pay across the globe	05-31	RE
Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal	05-29	MT
AstraZeneca drug lowers cholesterol in phase 1 trial	05-29	AN
Cellectis: operations financed until 2026	05-29	CF
Astrazeneca Says AZD0780 Demonstrated Significant LDL-C Reduction On Top Of Statin In Phase I Trial	05-29	RE
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	05-28	RE
AstraZeneca Says Potential Lung Cancer Treatment Improved Overall Survival Compared With Chemotherapy	05-28	MT
Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4	05-28	MT
AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients	05-27	DJ
AstraZeneca, Daiichi Sankyo’s Lung Cancer Drug Shows Mixed Results in Late-stage Trial	05-27	MT
AstraZeneca: favorable results in bronchial cancer	05-27	CF
AstraZeneca's Lung Cancer Drug Shows Clinically Meaningful Improvement in Overall Survival	05-27	MT
Astra, Daiichi hail positive survival data for Dato-DXd	05-27	AN
Daiichi Sankyo and AstraZeneca PLC Provides an update on TROPION-Lung01 Phase 3 Trial	05-27	CI
Innate Pharma: five abstracts selected for ASCO	05-24	CF
Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	05-23	MT

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm